Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation-Reference-Cited by-同舟云学术

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Published:2020-01 Issue:1 Volume:21 Page:e18-e28
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Guckenberger Matthias,Lievens Yolande,Bouma Angelique B,Collette Laurence,Dekker Andre,deSouza Nandita M,Dingemans Anne-Marie C,Fournier Beatrice,Hurkmans Coen,Lecouvet Frédéric E,Meattini Icro,Méndez Romero Alejandra,Ricardi Umberto,Russell Nicola S,Schanne Daniel H,Scorsetti Marta,Tombal Bertrand,Verellen Dirk,Verfaillie Christine,Ost Piet

Publisher

Elsevier BV

Subject

Oncology

Reference51 articles.

1. Oligometastases;Hellman;J Clin Oncol,1995

2. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial;Iyengar;JAMA Oncol,2018

3. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial;Ruers;J Natl Cancer Inst,2017

4. Local consolidative therapy vs maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study;Gomez;J Clin Oncol,2019

5. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019

Cited by 677 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OligoM-Cancer: A multidimensional information platform for deep phenotyping of heterogenous oligometastatic cancer;Computational and Structural Biotechnology Journal;2024-12

2. Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – A retrospective multicenter study of the Bavarian university hospitals;European Journal of Surgical Oncology;2024-12

3. Durable local control with hypofractionated radiation therapy for unresectable or metastatic melanoma;Clinical and Translational Radiation Oncology;2024-11

4. Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: Current evidence and future directions;Cancer Letters;2024-11

5. Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort;Radiotherapy and Oncology;2024-10